# Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy

> **NCT04829708** · PHASE3 · RECRUITING · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 534 (estimated)

## Conditions studied

- Limited Stage Small Cell Lung Cancer

## Interventions

- **OTHER:** MRI Surveillance
- **RADIATION:** Prophylactic Cranial Irradiation

## Key facts

- **NCT ID:** NCT04829708
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-26
- **Primary completion:** 2026-04-15
- **Final completion:** 2028-04-15
- **Target enrollment:** 534 (ESTIMATED)
- **Last updated:** 2021-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04829708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04829708, "Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04829708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*